Journal Mobile Options
Table of Contents
Vol. 74, No. 3-4, 2008
Issue release date: September 2008

Multifocal Epstein-Barr Virus-Associated Smooth Muscle Tumor in Adults with AIDS: Case Report and Review of the Literature

Gallien S. · Zuber B. · Polivka M. · Lagrange-Xelot M. · Thiebault J.-B. · Bertheau P. · Gray F. · Molina J.-M.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Objectives: The aim of this study was to provide a systematic review of Epstein-Barr virus-associated smooth muscle tumors (EBV-SMT) in human immunodeficiency virus (HIV)-infected adults, focusing on clinical and histopathologic features and outcome. Methods: A literature search was performed using Medline, Embase and the Cochrane Library. Results: We reviewed 35 cases including our case of a patient with a progressive multifocal EBV-SMT. Patients were mainly men (n = 24) with a mean age of 35.5 years. Median CD4 count was 21/mm3. Main locations were brain (n = 12), liver (n = 8), spinal cord (n = 7) and adrenal gland (n = 6). The tumors were multifocal in 34% of cases, whereas analysis of clonality showed different clones in tumors from different sites. Treatment included removal surgery in 17 cases and/or radiotherapy in 9 and therapeutic abstention in 4. Mean follow-up after diagnosis was 12.3 months. Nine patients died during this period essentially from opportunistic infection and only 2 from the disease. Conclusion: EBV-SMT should be added to the list of virally induced tumors in severely immunocompromised HIV-infected adults. Multifocality of independent tumor clones, especially in liver, brain, spinal cord and adrenal gland, and a slow disease progression seem to be the key features of these tumors, the treatment of which remains poorly defined.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Schwartz RS: Immunodeficiency, immunosuppression, and susceptibility to neoplasms. J Natl Cancer Inst Monogr 2001;28:5–9.

    External Resources

  2. Renwick N, Halaby T, Weverling GJ, Dukers NH, Simpson GR, Coutinho RA, Lange JM, Schulz TF, Goudsmit J: Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi’s sarcoma. AIDS 1998;12:2481–2488.
  3. Laurence J, Astrin SM: Human immunodeficiency virus induction of malignant transformation in human B lymphocytes. Proc Natl Acad Sci USA 1991;88:7635–7639.
  4. Morgello S: Epstein-Barr and human immunodeficiency viruses in acquired immunodeficiency syndrome-related primary central nervous system lymphoma. Am J Pathol 1992;141:441–450.
  5. Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC Jr: Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997;337:1343–1349.
  6. Palefsky JM, Holly EA, Ralston ML, Da Costa M, Greenblatt RM: Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis 2001;183:383–391.
  7. Baumforth KR, Young LS, Flavell KJ, Constandinou C, Murray PG: The Epstein-Barr virus and its association with human cancers. Mol Pathol 1999;52:307–322.
  8. Lee ES, Locker J, Nalesnik M, Reyes J, Jaffe R, Alashari M, Nour B, Tzakis A, Dickman PS: The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med 1995;332:19–25.
  9. Chadwick EG, Connor EJ, Hanson IC, Joshi VV, Abu-Farsakh H, Yogev R, McSherry G, McClain K, Murphy SB: Tumors of smooth-muscle origin in HIV-infected children. JAMA 1990;263:3182–3184.
  10. Deyrup AT, Lee VK, Hill C, Cheuk W, Toh HC, Kesavan S, Chan EW, Weiss SW: Epstein-Barr virus-associated smooth muscle tumors are distinctive mesenchymal tumors reflecting multiple infection events: a clinicopathologic and molecular analysis of 29 tumors from 19 patients. Am J Surg Pathol 2006;30:75–82.
  11. McClain KL, Leach CT, Jenson HB, Joshi VV, Pollock BH, Parmley RT, DiCarlo FJ, Chadwick EG, Murphy SB: Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med 1995;332:12–18.
  12. Goedert JJ, Cote TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, Jaffe ES, Biggar RJ: Spectrum of AIDS-associated malignant disorders. Lancet 1998;351:1833–1839.
  13. Calderaro J, Polivka M, Gallien S, Bertheau P, Thiebault JB, Molina JM, Gray F: Multifocal Epstein Barr virus (EBV)-associated myopericytoma in a patient with AIDS. Neuropathol Appl Neurobiol 2008;34:115–117.
  14. Jenson HB, Leach CT, McClain KL, Joshi VV, Pollock BH, Parmley RT, Chadwick EG, Murphy SB: Benign and malignant smooth muscle tumors containing Epstein-Barr virus in children with AIDS. Leuk Lymphoma 1997;27:303–314.
  15. Enzinger FM, Weiss SW: Benign tumors of smooth muscle; in Enzinger FM, Weiss SW (eds): Soft Tissue Tumors, ed 3. St. Louis, Mosby, 1995, pp 467–490.
  16. Sprogoe-Jakobsen S, Holund B: Immunohistochemistry (Ki-67 and p53) as a tool in determining malignancy in smooth muscle neoplasms (exemplified by a myxoid leiomyosarcoma of the uterus). APMIS 1996;104:705–708.
  17. Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, de Mascarel A, Goussot JF, David M, Bonichon F, Lagarde C: Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984;33:37–42.
  18. Zevallos-Giampietri EA, Yanes HH, Orrego Puelles J, Barrionuevo C: Primary meningeal Epstein-Barr virus-related leiomyosarcoma in a man infected with human immunodeficiency virus: review of literature, emphasizing the differential diagnosis and pathogenesis. Appl Immunohistochem Mol Morphol 2004;12:387–391.
  19. Prevot S, Neris J, de Saint Maur PP: Detection of Epstein Barr virus in an hepatic leiomyomatous neoplasm in an adult human immunodeficiency virus 1-infected patient. Virchows Arch 1994;425:321–325.
  20. Boman F, Gultekin H, Dickman PS: Latent Epstein-Barr virus infection demonstrated in low-grade leiomyosarcomas of adults with acquired immunodeficiency syndrome, but not in adjacent Kaposi’s lesion or smooth muscle tumors in immunocompetent patients. Arch Pathol Lab Med 1997;121:834–838.
  21. Crawford DH: Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 2001;356:461–473.
  22. Suankratay C, Shuangshoti S, Mutirangura A, Prasanthai V, Lerdlum S, Shuangshoti S, Pintong J, Wilde H: Epstein-Barr virus infection-associated smooth-muscle tumors in patients with AIDS. Clin Infect Dis 2005;40:1521–1528.
  23. Birx DL, Redfield RR, Tosato G: Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N Engl J Med 1986;314:874–879.
  24. Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX: Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Cancer 2004;100:1162–1170.
  25. Van Baarle D, Wolthers KC, Hovenkamp E, Niesters HG, Osterhaus AD, Miedema F, Van Oers MH: Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma. J Infect Dis 2002;186:405–409.
  26. Ross JS, Del Rosario A, Bui HX, Sonbati H, Solis O: Primary hepatic leiomyosarcoma in a child with the acquired immunodeficiency syndrome. Hum Pathol 1992;23:69–72.
  27. Morgello S, Kotsianti A, Gumprecht JP, Moore F: Epstein-Barr virus-associated dural leiomyosarcoma in a man infected with human immunodeficiency virus. Case report. J Neurosurg 1997;86:883–887.
  28. Bluhm JM, Yi ES, Diaz G, Colby TV, Colt HG: Multicentric endobronchial smooth muscle tumors associated with the Epstein-Barr virus in an adult patient with the acquired immunodeficiency syndrome: a case report. Cancer 1997;80:1910–1913.
  29. Kleinschmidt-DeMasters BK, Mierau GW, Sze CI, Breeze RE, Greffe B, Lillehei KO, Stephens JK: Unusual dural and skull-based mesenchymal neoplasms: a report of four cases. Hum Pathol 1998;29:240–245.
  30. Grulich AE, Li Y, McDonald AM, Correll PK, Law MG, Kaldor JM: Decreasing rates of Kaposi’s sarcoma and non-Hodgkin’s lymphoma in the era of potent combination anti-retroviral therapy. AIDS 2001;15:629–633.
  31. Davidoff AM, Hebra A, Clark BJ 3rd, Tomaszewski JE, Montone KT, Ruchelli E, Lau HT: Epstein-Barr virus-associated hepatic smooth muscle neoplasm in a cardiac transplant recipient. Transplantation 1996;61:515–522.
  32. To KF, Lai FM, Wang AY, Leung CB, Choi PC, Szeto CC, Lui SF, Yu AW, Li PK: Posttransplant Epstein-Barr virus-associated myogenic tumors involving bone. Cancer 2000;89:467–472.
  33. Wang MH, Wu CT, Hung CC, Liang JD, Chen PJ: Hepatic leiomyomatous neoplasm associated with Epstein Barr virus infection in an adult with acquired immunodeficiency syndrome. J Formos Med Assoc 2000;99:873–875.
  34. Cheuk W, Li PC, Chan JK: Epstein-Barr virus-associated smooth muscle tumour: a distinctive mesenchymal tumour of immunocompromised individuals. Pathology 2002;34:245–249.
  35. Zetler PJ, Filipenko JD, Bilbey JH, Schmidt N: Primary adrenal leiomyosarcoma in a man with acquired immunodeficiency syndrome (AIDS). Further evidence for an increase in smooth muscle tumors related to Epstein-Barr infection in AIDS. Arch Pathol Lab Med 1995;119:1164–1167.
  36. Brown HG, Burger PC, Olivi A, Sills AK, Barditch-Crovo PA, Lee RR: Intracranial leiomyosarcoma in a patient with AIDS. Neuroradiology 1999;41:35–39.
  37. Ritter AM, Amaker BH, Graham RS, Broaddus WC, Ward JD: Central nervous system leiomyosarcoma in patients with acquired immunodeficiency syndrome. Report of two cases. J Neurosurg 2000;92:688–692.
  38. Karpinski NC, Yaghmai R, Barba D, Hansen LA: Case of the month: March 1999 – a 26 year old HIV positive male with dura based masses. Brain Pathol 1999;9:609–610.
  39. Chang JY, Wang S, Hung CC, Tsai TF, Hsiao CH: Multiple Epstein-Barr virus-associated subcutaneous angioleiomyomas in a patient with acquired immunodeficiency syndrome. Br J Dermatol 2002;147:563–567.
  40. Blumenthal DT, Raizer JJ, Rosenblum MK, Bilsky MH, Hariharan S, Abrey LE: Primary intracranial neoplasms in patients with HIV. Neurology 1999;52:1648–1651.
  41. Wong KH, Chan KC, Lee SS, Lai ST, Lee N, Cockram C, Poon WS, Tsang TY, Tso YK, To KF: Epstein-Barr virus-associated smooth muscle tumor in patients with acquired immunodeficiency syndrome. J Microbiol Immunol Infect 2007;40:173–177.

    External Resources



Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50